Abstract
Three patients treated with bilateral subcutaneous mastectomies and implants for fibrocystic disease or carcinoma in situ subsequently developed invasive breast carcinoma. These cases emphasize that subcutaneous mastectomy does not prevent the development of breast cancer. If the circumstances in an individual patient justify prophylactic mastectomy, then the appropriate procedure would seem to be total mastectomy, which would accomplish thorough removal of all breast tissue, the subareolar region, and the nipple. Subcutaneous mastectomy for the patient who is likely to harbor occult invasive disease seems particularly inappropriate. As a means to reduce the risk of breast cancer, the procedure is unproved and must be considered an experimental therapeutic approach.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 198-201 |
| Number of pages | 4 |
| Journal | Journal of Surgical Oncology |
| Volume | 26 |
| Issue number | 3 |
| State | Published - 1984 |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Surgery
Cite this
Failure of subcutaneous mastectomy to prevent the development of breast cancer. / Goodnight Jr, James E; Quagliana, J. M.; Morton, D. L.
In: Journal of Surgical Oncology, Vol. 26, No. 3, 1984, p. 198-201.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Failure of subcutaneous mastectomy to prevent the development of breast cancer
AU - Goodnight Jr, James E
AU - Quagliana, J. M.
AU - Morton, D. L.
PY - 1984
Y1 - 1984
N2 - Three patients treated with bilateral subcutaneous mastectomies and implants for fibrocystic disease or carcinoma in situ subsequently developed invasive breast carcinoma. These cases emphasize that subcutaneous mastectomy does not prevent the development of breast cancer. If the circumstances in an individual patient justify prophylactic mastectomy, then the appropriate procedure would seem to be total mastectomy, which would accomplish thorough removal of all breast tissue, the subareolar region, and the nipple. Subcutaneous mastectomy for the patient who is likely to harbor occult invasive disease seems particularly inappropriate. As a means to reduce the risk of breast cancer, the procedure is unproved and must be considered an experimental therapeutic approach.
AB - Three patients treated with bilateral subcutaneous mastectomies and implants for fibrocystic disease or carcinoma in situ subsequently developed invasive breast carcinoma. These cases emphasize that subcutaneous mastectomy does not prevent the development of breast cancer. If the circumstances in an individual patient justify prophylactic mastectomy, then the appropriate procedure would seem to be total mastectomy, which would accomplish thorough removal of all breast tissue, the subareolar region, and the nipple. Subcutaneous mastectomy for the patient who is likely to harbor occult invasive disease seems particularly inappropriate. As a means to reduce the risk of breast cancer, the procedure is unproved and must be considered an experimental therapeutic approach.
UR - http://www.scopus.com/inward/record.url?scp=0021136395&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021136395&partnerID=8YFLogxK
M3 - Article
VL - 26
SP - 198
EP - 201
JO - Journal of Surgical Oncology
JF - Journal of Surgical Oncology
SN - 0022-4790
IS - 3
ER -